Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB04893> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04893 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04893 label "AZD3409 [drugbank:DB04893]" assertion.
- drugbank:DB04893 seeAlso DB04893 assertion.
- drugbank:DB04893 description "AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been discontinued." assertion.
- drugbank:DB04893 identifier "drugbank:DB04893" assertion.
- drugbank:DB04893 title "AZD3409" assertion.
- drugbank:DB04893 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB04893 drugbank_vocabulary:drugbank-id "DB04893" assertion.
- drugbank:DB04893 bio2rdf_vocabulary:x-identifiers.org DB04893 assertion.
- drugbank:DB04893 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04893" assertion.
- drugbank:DB04893 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04893 bio2rdf_vocabulary:identifier "DB04893" assertion.